Biomarin Pharmaceutical Revenue, Growth & Competitor Profile

DBA BIOMARIN

Company Profile & Annual Report for Biomarin Pharmaceutical

Access the complete profile.

Biomarin Pharmaceutical Fast Facts

Revenue	Over $500 million    See Exact Annual Revenue
Employees	Over 1,000Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing 5417 Scientific Research & Development Services
Address	770 Lindaro St San Rafael, CA 94901

Biomarin Pharmaceutical's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Biomarin Pharmaceutical's annual revenues are Over $500 million (see exact revenue data)
• What industry is the company in?
  • Biomarin Pharmaceutical is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Biomarin Pharmaceutical is a publicly traded company on using the ticker symbol BMRN. Detailed information on company financials and operating reports can be found here: : BMRN

Biomarin Pharmaceutical Annual Revenue and Growth Rate

Biomarin Pharmaceutical	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	Over $500 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Biomarin Pharmaceutical's revenues are gauged from an analysis of company filings.

Trademark Applications

Trademark applications show the products and services that Biomarin Pharmaceutical is developing and marketing. Biomarin Pharmaceutical doesn't have any recent trademark applications, indicating Biomarin Pharmaceutical is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
NUSTARZA Pharmaceutical preparations for the treatment of genetic diseases and disorders	06/15/2023
ACHONDROPLASIA DOCTOR FINDER Providing an online searchable database to locate healthcare providers caring for children with achondroplasia	08/10/2022
HEMOPHILIA: THE MUSICAL Entertainment services in the nature of live theatrical performances; Educational services, namely, conducting workshops in the field of living with hemophilia, and distribution of training material in connection therewith	11/03/2020

See all trademarks and details in the Full Report.

Market Share of Biomarin Pharmaceutical's Largest Competitors

A competitive analysis shows these companies are in the same general field as Biomarin Pharmaceutical, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Biomarin Pharmaceutical. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
BIOMARIN PHARMACEUTICAL	San Rafael, CA	100
ULTRAGENYX PHARMACEUTICAL	Novato, CA	66
HAHNEMANN LABORATORIES	San Rafael, CA	1
MERCAPTOR DISCOVERIES	Novato, CA	0
KNEE JOINT	Mill Valley, CA	0
OPTISOMIX	Belvedere Tiburon, CA	0

Future Competition: Biomarin Pharmaceutical's Fastest Growing Competitors

These companies are in the same general field as Biomarin Pharmaceutical and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)